The growing demand for controlled immunological investigation and therapeutic design has spurred significant advances in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently generated using multiple expression platforms, including prokaryotic hosts, animal cell cultures, and vi